Last Updated:
Searching
Create account to add to watchlist!

Oxbridge Acquisition Corp. - OXAC

  • Commons

    $9.94

    -0.24%

    OXAC Vol: 841.0

  • Warrants

    $0.48

    -0.40%

    OXACW Vol: 3.7K

  • Units

    $10.41

    -0.29%

    OXACU Vol: 0.0

Average: 0
Rating Count: 0
You Rated: Not rated

Please log in to rate.

SPAC Stats

Market Cap: 115.5M
Average Volume: 79.4K
52W Range: $9.76 - $10.48
Weekly %: +0.20%
Monthly %: +0.10%
Inst Owners: nan

Info

Target: Searching
Days Since IPO: 109
Unit composition:
Each unit has an offering price of $10.00 and consists of one of our Class A ordinary shares and one redeemable warrant
Trust Size: 10000000.0M

🕵Stocktwit Mentions

WarrenGShirley posted at 2021-11-16T22:46:31Z

$OXAC just shy of 600k warrants traded and 12% gain 💪

WarrenGShirley posted at 2021-11-16T17:11:41Z

@Imdbcooper200k @Tahoeblues A randomly timed pump over at $OXAC on warrants has somehow balanced this day off, so when BREZ wakes up I’ll be way green

WarrenGShirley posted at 2021-11-16T16:54:51Z

$OXAC warrants catching unusual volume and buying pressure 👀

WarrenGShirley posted at 2021-11-15T20:45:24Z

$OXAC picking up more warrants under $.50

WarrenGShirley posted at 2021-11-15T20:44:39Z

@believeinturtlegang nice! I keep finding myself buying more $OXAC anytime I see it dip under $.50 Those searching: Disruptive Tech: InsurTech, blockchain and artificial intelligence

Last10K posted at 2021-11-15T12:08:22Z

$OXAC just filed a 10-Q Quarterly Report with 26 sections and 4 exhibits. Access them all or just read their earnings: https://last10k.com/sec-filings/oxac/0001493152-21-028279.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=10KQ2040F&utm_term=oxac

Quantisnow posted at 2021-11-15T11:39:56Z

$OXAC 📜 SEC Form 10-Q filed by Oxbridge Acquisition Corp. https://quantisnow.com/insight/2005539?s=s 45 seconds delayed.

Newsfilter posted at 2021-11-15T11:39:06Z

$OXAC Form 10-Q (quarterly report [sections 13 or 15(d)]) filed with the SEC https://newsfilter.io/a/e5a02a109c63914771f715aade4ab123

WarrenGShirley posted at 2021-11-12T15:32:02Z

I did some math on this quiet morning and might as well share: $BREZ $BENE $IMAQ $BMAQ $OXAC

J_Will posted at 2021-11-11T19:30:16Z

$OXAC Bought warrants .4777 Thanks @WarrenGShirley for pointing this one and a few others out.

WarrenGShirley posted at 2021-11-11T03:48:42Z

@Sea_JK i narrowed that list down from my list of 30 pre-DA SPCs that I hold 😬 If you’re into rights BMAQ has a ton of hype for this early and management is proven in the blockchain industry Top 2 fave Warrants $CLAQ - managed by Jon Najarian (Co-Founder of Market Rebellion, CNBC contributor), Governor Bill Richardson (Former Governor of New Mexico) (Lots of EV tech in NM) And $OXAC - Disruptive Tech: InsurTech, blockchain and artificial intelligence $116,725,000 trust, did I list this one above? Keep in mind I sort all 1:1 SPAC warrants by price and start to accumulate the cheeper ones with interesting management or target sector when the price dips, so I add warrants every day and I don’t really care what happens day to day because I’m waiting for the first rumore or DA to start scaling out. I sell 50% of what I hold every 100% gain until I’m down to nearly nothing.

WarrenGShirley posted at 2021-11-10T18:44:22Z

$OXAC picked up another 2k warrants @ $.4874

DevilsGrave posted at 2021-11-05T14:28:25Z

$OXAC got 65000 warrants. Let's GOOO

WarrenGShirley posted at 2021-11-04T18:14:18Z

$OXAC picked up another 2k warrants here at $.4789

WarrenGShirley posted at 2021-11-04T02:18:15Z

@realDickButkus I feel like a real idiot not buying more KWAC when it dipped into the $.40’s, but yes 16k $OXAC , 20k $IMAQ , and 15k BENE rights, only 2200 $KWAC 🤦‍♂️

WarrenGShirley posted at 2021-11-03T20:30:51Z

$OXAC searching Disruptive Tech: InsurTech, blockchain and artificial intelligence

MikeHockInbahls posted at 2021-11-01T15:11:20Z

$OXAC let's go!

Dyler94 posted at 2021-11-01T00:38:10Z

$OXAC follow my twitter for free stock alerts @ Dyler94 🤯

MoneyLover1010 posted at 2021-10-29T19:23:26Z

$OXAC I bought some OXAC and OXACW, curious to see if this will get some attention next week.

Jaydre111 posted at 2021-10-29T18:25:52Z

$OXAC this shit just skyrocketed baby,lol

MikeHockInbahls posted at 2021-10-29T14:15:58Z

$OXAC Forgot about this one!

WarrantsGBuffett posted at 2021-10-29T02:14:28Z

$OXAC Warrens looking for Warrants!

JxP2000 posted at 2021-10-29T01:49:40Z

$OXAC what even is this lol

WarrenGShirley posted at 2021-10-29T01:47:42Z

$OXAC $MEOA $IMAQ $CLAQ $CENQ FOR ALL THE PRE-DA DEGENS, WELCOME HOME 😝

WarrantsGBuffett posted at 2021-10-29T00:48:56Z

$OXAC Bout to eat those warrants up tomorrow at the bell

Hotrod2 posted at 2021-10-29T00:31:45Z

$OXAC lots of 6s here, I'll take lucky number 7

Hotrod2 posted at 2021-10-29T00:29:35Z

$OXAC 6th watcher Let's roll😂😂

MakeMyAccountGreatAgain posted at 2021-10-29T00:23:27Z

$OXAC 🙋‍♂️

SKIK posted at 2021-10-29T00:22:46Z

$OXAC join you all here !

Snowliontothemoon posted at 2021-10-29T00:18:01Z

$OXAC I arrive wherever there is money..

Management

Officers and Directors Cayman Islands law does not limit the extent to which a company’s memorandum and articles of association may provide for indemnification of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against willful default, fraud or the consequences of committing a crime. Our amended and restated memorandum and articles of association will provide for indemnification of our officers and directors to the maximum extent permitted by applicable law, including for any liability incurred in their capacities as such, except through their own actual fraud or willful default. We may purchase a policy of directors’ and officers’ liability insurance that insures our officers and directors against the cost of defense, settlement or payment of a judgment in some circumstances and insures us against our obligations to indemnify our officers and directors. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. 130 Principal Shareholders The following table sets forth information regarding the beneficial ownership of our ordinary shares as of the date of this prospectus, and as adjusted to reflect the sale of our ordinary shares included in the units offered by this prospectus, and assuming no purchase of units in this offering, by: ● each person known by us to be the beneficial owner of more than 5% of our outstanding shares of ordinary shares; ● each of our executive officers and directors that beneficially owns shares of our ordinary shares; and ● all our executive officers and directors as a group. Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all shares of ordinary shares beneficially owned by them. The following table does not reflect record or beneficial ownership of the private placement warrants as these warrants are not exercisable within 60 days of the date of this prospectus. On April 12, 2021, our sponsor paid an aggregate of $25,000 to purchase 2,875,000 founder shares, or approximately $0.009 per share. Prior to the initial investment in the company of $25,000 by the sponsor, the company had no assets, tangible or intangible. The purchase price of the founder shares was determined by dividing the amount of cash contributed to the company by the number of founder shares issued. The number of founder shares outstanding was determined based on the expectation that the total size of this offering would be a maximum of 11,500,000 units if the underwriter’s over-allotment option is exercised in full, and therefore that such founder shares would represent 20% of the outstanding shares after this offering. Up to 375,000 of the founder shares will be forfeited depending on the extent to which the underwriter’s over-allotment is exercised. The post-offering percentages in the following table assume that the underwriter does not exercise its over-allotment option, that our initial shareholders have forfeited 375,000 founder shares, and that there are 12,500,000 shares of ordinary shares issued and outstanding after this offering. Ordinary Shares Before Offering After Offering Name and Address of Beneficial Owner(1) Number of Shares Beneficially Owned(2) Approximate Percentage of Outstanding Ordinary shares Number of Shares Beneficially Owned(2) Approximate Percentage of Outstanding Ordinary shares OAC Sponsor Ltd. (3) 2,875,000(4) 100.0% 2,500,000 19.8% Jay Madhu - -% - -% Wrendon Timothy - -% - -% Allan Martin - -% - -% Jason Butcher - -% - -% William L. Yankus - -% - -% All executive officers and directors as a group (5 individuals) 2,875,000 100.0% 2,500,000 19.8% (1) Unless otherwise noted, the business address of each of the following entities or individuals is c/o Oxbridge Acquisition Corp., Suite 201, 42 Edward Street, Georgetown, Grand Cayman, Cayman Islands. (2) Interests shown consist solely of founder shares, which are shares of Class B ordinary shares. Such shares are convertible into Class A ordinary shares on a one-for-one basis, subject to adjustment, as described in the section of this prospectus entitled “Description of Securities”. 131 (3) OAC Sponsor Ltd., our sponsor, is the record holder of the 2,875,000 shares reported herein. OAC Sponsor Ltd. is governed and controlled by a board of directors of 3 members, Jay Madhu, Wrendon Timothy and Isabel Gumeyi. Each director has one vote, and the approval of a majority is required to approve an action. Under the so-called “rule of three,” if voting and dispositive decisions regarding an entity’s securities are made by two or more individuals, and a voting and dispositive decision requires the approval of a majority of those individuals, none of the individuals is deemed a beneficial owner of the entity’s securities. This is the situation with regard to OAC Sponsor Ltd. Based on the foregoing, no director exercises voting or dispositive control over any of the securities held by OAC Sponsor Ltd. Accordingly, none of them will be deemed to have or share beneficial ownership of such shares and, for the avoidance of doubt, each expressly disclaims any such beneficial interest to the extent of any pecuniary interest he may have therein, directly or indirectly. Each of our officers, directors and advisors is or will be, directly or indirectly, a member of our sponsor. (4) Includes up to 375,000 founder shares that may be surrendered for no consideration depending on the extent to which the underwriters’ over-allotment option is exercised. Immediately after this offering, our initial shareholders will beneficially own 20% of the then-issued and outstanding shares of our ordinary shares (assuming they do not purchase any units in this offering and excluding Class A ordinary shares issuable to the underwriters upon the closing of this offering). If we increase or decrease the size of the offering, we will effect a share dividend or a share contribution back to capital, or other appropriate mechanism, as applicable, with respect to our Class B ordinary shares immediately prior to the consummation of the offering in such amount as to maintain the ownership of our initial shareholders at 20% of our issued and outstanding shares of ordinary shares upon the consummation of this offering(excluding Class A ordinary shares issuable to the underwriters upon the closing of this offering). Because of their ownership block, our initial shareholders may be able to effectively influence the outcome of all other matters requiring approval by our shareholders, including amendments to our amended and restated memorandum and articles of association and approval of significant corporate transactions. The holders of the founder shares have agreed: (A) to vote any shares owned by them in favor of any proposed initial business combination; and (B) not to redeem any shares in connection with a shareholder vote to approve a proposed initial business combination or in connection with a tender offer. Our sponsor and our executive officers and directors are deemed to be our “promoters” as such term is defined under the federal securities laws. 132 Restrictions on Transfers of Founder Shares and Private Placement Warrants The founder shares, private placement warrants, and any Class A ordinary shares issued upon conversion or exercise thereof are each subject to transfer restrictions pursuant to lock-up provisions in a letter agreement with us to be entered into by our sponsor, officers and directors. Our initial shareholders have agreed not to transfer, assign or sell any of their founder shares until the earlier to occur of: (i) one year after the date of the consummation of our initial business combination; or (ii) the date on which we consummate a liquidation, merger, stock exchange, or other similar transaction that results in all of our shareholders having the right to exchange their Class A ordinary shares for cash, securities, or other property (except as described herein under the section of this prospectus entitled “Principal Shareholders — Restrictions on Transfers of Founder Shares and Private Placement Warrants”). Any permitted transferees will be subject to the same restrictions and other agreements of our initial shareholders with respect to any founder shares. Notwithstanding the foregoing, if the closing price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing 150 days after our initial business combination, the founder shares will no longer be subject to such transfer restrictions. In addition, the lock-up provisions of the insider letter provide that the founder shares and the private placement warrants, and any Class A ordinary shares issued upon conversion or exercise thereof are not transferable or salable until 30 days after the completion of our initial business combination. However, any such securities may be transferred or sold: (a) to our officers or directors, any affiliates or family members of any of our officers or directors, any members of our sponsor, or any affiliates of our sponsor; (b) in the case of an individual, by gift to a member of the individual’s immediate family or to a trust, the beneficiary of which is a member of one of the individual’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with the consummation of an initial business combination at prices no greater than the price at which the securities were originally purchased; (f) in the event of our liquidation prior to the completion of our initial business combination; (g) by virtue of the laws of Florida or our sponsor’s limited liability company agreement upon dissolution of our sponsor; or (h) in the event of our liquidation, merger, capital stock exchange, reorganization or other similar transaction which results in all of our shareholders having the right to exchange their shares of ordinary shares for cash, securities or other property subsequent to our completion of our initial business combination; provided, however, that in the case of clauses (a) through (e) or (g) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreements, and by the same agreements entered into by our sponsor with respect to such securities (including provisions relating to voting, the trust account, and liquidation distributions described elsewhere in this prospectus). Registration Rights The holders of the (i) founder shares, which were issued in a private placement prior to the closing of this offering, (ii) private placement warrants, which will be issued in a private placement simultaneously with the closing of this offering and the Class A ordinary shares underlying such private placement warrants and (iii) private placement warrants that may be issued upon conversion of working capital loans will have registration rights to require us to register a sale of any of our securities held by them pursuant to a registration rights agreement to be signed prior to or on the effective date of this offering. Pursuant to the registration rights agreement and assuming the underwriter exercises its over-allotment option in full and $1,500,000 of working capital loans are converted into private placement warrants, we will be obligated to register up to 10,135,000 Class A ordinary shares and 7,160,000 warrants. The number of Class A ordinary shares includes (i) 2,875,000 Class A ordinary shares to be issued upon conversion of the founder shares, (ii) 4,897,500 Class A ordinary shares underlying the private placement warrants, (iii) 862,500 Class A ordinary shares underlying the representative warrants and (iv) 1,500,000 Class A ordinary shares underlying the private placement warrants issued upon conversion of working capital loans. The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to our completion of our initial business combination. We will bear the expenses incurred in connection with the filing of any such registration statements 133 Certain Relationships and Related Party Transactions On April 12, 2021, we issued an aggregate of 2,875,000 founder shares to our sponsor (up to 375,000 shares of which are subject to forfeiture depending on the extent to which the underwriters’ over-allotment option is exercised) for an aggregate purchase price of $25,000 in cash, or approximately $0.009 per share. The number of founder shares issued was determined based on the expectation that such founder shares would represent 20% of the outstanding shares upon completion of this offering (not including the Class A ordinary shares issuable to Maxim). If we increase or decrease the size of the offering we will effect a share dividend or a share contribution back to capital or other appropriate mechanism, as applicable, with respect to our Class B ordinary shares immediately prior to the consummation of the offering in such amount as to maintain the ownership of our initial shareholders at 20.0% of the issued and outstanding shares of our ordinary shares upon the consummation of this offering (not including the Class A ordinary shares issuable to Maxim). Up to 375,000 founder shares are subject to forfeiture by our sponsor depending on the extent to which the underwriters’ over-allotment option is exercised. The founder shares (including the Class A ordinary shares issuable upon exercise thereof) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder until 30 days after the completion of our initial business combination. Our sponsor and Maxim have committed to purchase an aggregate of 5,235,000 private placement warrants (or 5,760,000 private placement warrants if the underwriter’s over-allotment option is exercised in full), each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.00 per warrant, in a private placement that will close simultaneously with the closing of this offering. The private placement warrants (including the Class A ordinary shares issuable upon exercise of the private placement warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold until 30 days after the completion of our initial business combination. As more fully discussed in the section of this prospectus entitled “Management—Conflicts of Interest,” if any of our officers or directors becomes aware of an initial business combination opportunity that falls within the line of business of any entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such business combination opportunity to such other entity. Our officers and directors currently have certain relevant fiduciary duties or contractual obligations that may take priority over their duties to us. Unless disclosed herein, no compensation of any kind, including finder’s and consulting fees, will be paid by us to our sponsor, officers and directors, or any of their respective affiliates, for services rendered prior to or in connection with the completion of an initial business combination. However, these individuals will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made to our sponsor, officers, directors or our or their affiliates and will determine which expenses and the amount of expenses that will be reimbursed. There is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred by such persons in connection with activities on our behalf. Upon the closing of this offering, we will issue to Maxim (or its designees) 100,000 representative shares (or 115,000 representative shares, if the over-allotment option is exercised in full) for nominal consideration. The holders of the representative shares have agreed not to transfer, assign or sell any such shares without our prior consent until the completion of our initial business combination. In addition, the holders of the representative shares have agreed to waive their rights to liquidating distributions from the trust account with respect to such shares if we fail to complete our initial business combination within 15 months from the closing of this offering. Our sponsor has agreed to loan us up to $300,000 under a promissory note to be used for a portion of the expenses of this offering. This loan will be non-interest bearing, unsecured and will be due at the earlier of September 30, 2021 or the closing of this offering. The loan will be repaid upon the closing of this offering out of the estimated $1,035,000 of offering proceeds that has been allocated to the payment of offering expenses (other than underwriting commissions). The value of our sponsor’s interest in this transaction corresponds to the principal amount outstanding under any such loan. 134 In addition, in order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete an initial business combination, we would repay such loaned amounts. In the event that the initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such

Holder Stats

1 0
% of Shares Held by All Insider NaN
% of Shares Held by Institutions NaN
% of Float Held by Institutions NaN
Number of Institutions Holding Shares NaN

SEC Filings

Form Type Form Description Filing Date Document Link
10-Q 2021-11-15 https://www.sec.gov/Archives/edgar/data/1861622/000149315221028279/form10-q.htm
8-K 2021-09-30 https://www.sec.gov/Archives/edgar/data/1861622/000149315221024200/form8-k.htm
10-Q 2021-09-27 https://www.sec.gov/Archives/edgar/data/1861622/000149315221023874/form10-q.htm
8-K 2021-08-24 https://www.sec.gov/Archives/edgar/data/1861622/000149315221021055/form8-k.htm
SC 13G 2021-08-20 https://www.sec.gov/Archives/edgar/data/1861622/000135755021000059/oxacu13g12aug2021.htm
SC 13G FORM SC 13G 2021-08-17 https://www.sec.gov/Archives/edgar/data/1861622/000106299321007638/formsc13g.htm
8-K 2021-08-17 https://www.sec.gov/Archives/edgar/data/1861622/000149315221020359/form8-k.htm
424B4 2021-08-13 https://www.sec.gov/Archives/edgar/data/1861622/000149315221019632/form424b4.htm
EFFECT 2021-08-11 https://www.sec.gov/Archives/edgar/data/1861622/999999999521003153/xslEFFECTX01/primary_doc.xml
3 FORM 3 2021-08-11 https://www.sec.gov/Archives/edgar/data/1861622/000156761921015100/xslF345X02/doc1.xml
3 FORM 3 2021-08-11 https://www.sec.gov/Archives/edgar/data/1861622/000156761921015097/xslF345X02/doc1.xml
3 FORM 3 2021-08-11 https://www.sec.gov/Archives/edgar/data/1861622/000156761921015095/xslF345X02/doc1.xml
3 FORM 3 2021-08-11 https://www.sec.gov/Archives/edgar/data/1861622/000156761921015093/xslF345X02/doc1.xml
3 FORM 3 2021-08-11 https://www.sec.gov/Archives/edgar/data/1861622/000156761921015091/xslF345X02/doc1.xml
3 FORM 3 2021-08-11 https://www.sec.gov/Archives/edgar/data/1861622/000156761921015089/xslF345X02/doc1.xml
CERT 2021-08-10 https://www.sec.gov/Archives/edgar/data/1861622/000135445721000915/8A_cert_OXAC.pdf
8-A12B 2021-08-09 https://www.sec.gov/Archives/edgar/data/1861622/000149315221019061/form8a-12b.htm
CORRESP 2021-08-09 https://www.sec.gov/Archives/edgar/data/1861622/000149315221019059/filename1.htm
CORRESP 2021-08-09 https://www.sec.gov/Archives/edgar/data/1861622/000149315221019057/filename1.htm
S-1/A 2021-07-30 https://www.sec.gov/Archives/edgar/data/1861622/000149315221018129/forms-1a.htm
CORRESP 2021-07-19 https://www.sec.gov/Archives/edgar/data/1861622/000149315221017122/filename1.htm
S-1 2021-07-19 https://www.sec.gov/Archives/edgar/data/1861622/000149315221017118/forms-1.htm
UPLOAD 2021-06-11 https://www.sec.gov/Archives/edgar/data/1861622/000000000021007241/filename1.pdf
DRS 2021-05-18 https://www.sec.gov/Archives/edgar/data/1861622/000149315221012171/filename1.htm